Health Care & Life Sciences » Pharmaceuticals | Mayne Pharma Group Ltd.

Mayne Pharma Group Ltd.

Mayne Pharma Group Ltd.
Stock Exchange Other OTC
EPS
$0.02
Market Cap
$605.95 M
Shares Outstanding
1.57 B
Public Float
-
Mayne Pharma Group Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.03
Market Cap
AUD846.87 M
Shares Outstanding
1.58 B
Public Float
1.35 B

Profile

Address
1538 Main North Road
Salisbury South Australia (SA) 5106
Australia
Employees -
Website http://www.maynepharma.com
Updated 07/08/2019
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products.

Financials

View All
Created with Highcharts 5.0.14Mayne Pharma Group Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.21 29021 2907 7597 75937 35537 35588 56788 567133 984133 98420142015201620172018025k50k75k100k125k150k
Created with Highcharts 5.0.14Mayne Pharma Group Ltd.Sales/Revenue. Fiscal year is July-June. All values AUD Thousands.143 254143 254141 420141 420267 280267 280572 595572 595530 313530 313201420152016201720180100k200k300k400k500k600k700k

Scott Richards
Chief Executive Officer, Executive Director & MD
Patrick J. Blake
Director